ArticleAdvances in therapy2018

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.

Edouard J Louis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.